Compare Stryker Corporation (SYK) vs UDR Inc. Common Stock (UDR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Stryker Corporation vs UDR Inc. Common Stock — how do they compare? Stryker Corporation trades at $285 (market cap $108.02B), while UDR Inc. Common Stock trades at $33.96 (market cap $10.91B). The key difference: Stryker Corporation is far larger — about 9.9× UDR Inc. Common Stock's market cap, and UDR Inc. Common Stock pays the higher dividend (5.12%). Which is the better fit depends on your goals — on Pluang, investors hold Stryker Corporation for 22 Days and UDR Inc. Common Stock for 0 Days on average.
| SYK | UDR | |
|---|---|---|
Market Cap | $108.02B | $10.91B |
Volume | 2,222,698 | 3,347,873 |
Sector | Health | Real Estate |
52-Week High | $388.35 | $41.24 |
52-Week Low | $269.75 | $33.27 |
Typical Hold Time | 22 Days | 0 Days |
Enterprise Value | $119.49B | $16.95B |
Dividend Yield | 1.25% | 5.12% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Stryker (SYK) trades at $282.63, showing minimal daily movement. The stock exhibits a neutral technical stance with mixed moving averages and oscillators. Fundamentally, SYK maintains strong profitability with a 14.43% net income margin and 16.51% ROE, though a P/E of 29.28 suggests a premium valuation. Recent news highlights ongoing legal scrutiny over a manufacturing issue disclosed in September 2026, which caused a significant price drop. Q3 2026 earnings are anticipated on October 29, 2026, following a mix of beats and misses in prior quarters.
The outlook for SYK is cautiously optimistic, supported by analyst consensus with a $365.89 price target and no sell ratings. Investment appeal lies in its solid cash flow and market position, but risks include legal investigations and persistent operational challenges. The stock's near-term direction will likely hinge on Q3 earnings results and clarity on the manufacturing issue resolution.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Stryker Corporation
Stryker is a global leader in medical technology, specializing in Orthopaedics, MedSurg, and Neurotechnology. It is renowned for its highly decentralized business model, which empowers 22 specialized business units to drive innovation and category leadership. With its market-leading Mako SmartRobotics™ platform and a relentless M&A strategy, Stryker provides a comprehensive ecosystem of connected surgical tools, implants, and digital solutions that improve both clinical and financial outcomes for hospitals worldwide.
Read more on SYK →About UDR Inc. Common Stock
UDR, Inc. is a self-administered real estate investment trust that owns, operates, develops, and redevelops multifamily apartment communities across targeted US markets. The company generates income primarily through leasing apartment homes, with a portfolio concentrated in coastal and Sunbelt metropolitan areas.
Read more on UDR →
